首页> 外文期刊>Korean Circulation Journal >Heart Transplantaion : Early Results and 2-Year Survival
【24h】

Heart Transplantaion : Early Results and 2-Year Survival

机译:心脏移植:早期结果和2年生存率

获取原文
       

摘要

Background The heart transplantation is now accepted as a definitive therapeutic modality in patients with terminal heart failure. The first successful heart transplantation in human was done in 1967 and the first case in Korea was performed in November, 1992. Since the first case in 1992, more than 25 cases have been performed in Korea. The purpose of this study is to evaluate the early results and the follow-up course of 9 cases of heart transplantation done in Asan Medical Center. Methods Total 9 patients had orthotopic heart transplantation since November, 1992 in Asan Medicla Center. The No. of male patients was 7 and the average age of 9 patients was 41 years old(20-51). The preoperation status was status I in 5 patients and status II in 4 patients. The mean follow-up duration was 9.5 months(2-26). All patients are alive till now. Results 1) The blood type was identical in 6 and compatible in 3 patients. 2) The original heart disease was dilated cardiomyopathy in 7, ischemic cardiomyopathy in 1 and giant cell myocarditis in 1 patient. 3) IgG Ab for CMV was positive in all recipients and donors and igM Ab for CMV was positive in only one reipient. The serial cultures for CMV shell vial method have been negative till now. 4) HLA cross matching for recipient and donor was done in 8 cases and the results were all negative for T-cell and B-cell. Among 6 loci of A, B and DR, one locus was matched in 4 cases and 2 loci was matched in 2 cases. 5) The No. of acute allograft rejection per case was average 3.7(1-6) and the No. of acute allograft rejection requiring treatment was average 1.4(1-3) per case. The time interval from operation to the first acute rejection requiring treatment was 40 days(5-60). Acute humoral rejection was supected strongly in 1 case and was successfully treated. 6) The left ventricular ejection fraction measured by echocardiography and/or MUGA scan was dramatically increased from 15%(10-24) to 59%(45-70%) after heart transplantation. 7) Temporary pacing was needed in 2 parients over24 hours but normal sinus rhythm was appeared within 7 day in all cases. One patient had permanent pacemaker due to complte AV block appeared 140 days after heart transplantaion. Conclusion The heart transplantation of Asan Medical Center is on developing stage but the early result is comparable to that of well established center in other countries, even though the long-term follow-up result must be reevaluated. We can conclude that the heart transplantion is a promising therapeutic option in parients with terminal heart failure.
机译:背景技术现在,心脏移植已被认为是晚期心力衰竭患者的一种确定的治疗方式。首次成功的人类心脏移植手术于1967年完成,韩国的第一例病例于1992年11月完成。自1992年的第一例以来,​​韩国已进行了25例以上。这项研究的目的是评估在牙山医学中心进行的9例心脏移植的早期结果和随访过程。方法自1992年11月以来,在Asan Medicla中心共进行了9例原位心脏移植手术。男性患者为7例,平均年龄为9岁,年龄41岁(20-51岁)。术前状态为5例为I状态,4例为II值。平均随访时间为9.5个月(2-26)。到目前为止,所有患者还活着。结果1)6例患者的血型相同,3例患者的血型相同。 2)最初的心脏病是扩张型心肌病,其中7例是缺血性心肌病,1例是巨细胞心肌炎。 3)在所有接受者和供体中,CMV的IgG Ab均为阳性,只有一位接受者的CMV igM Ab呈阳性。迄今为止,CMV外壳样品瓶方法的系列培养均为阴性。 4)在8例中完成了受体和供体的HLA交叉匹配,结果T细胞和B细胞均为阴性。在A,B和DR的6个基因座中,有4个病例匹配了一个基因座,在2例中匹配了2个基因座。 5)每例平均异种移植急性排斥反应数为3.7(1-6),需要治疗的平均同种异体移植排斥反应平均数为1.4(1-3)。从手术到第一次急性排斥反应需要治疗的时间间隔是40天(5-60)。强烈建议急性体液排斥反应1例,并已成功治疗。 6)心脏移植后,通过超声心动图和/或MUGA扫描测得的左心室射血分数从15%(10-24)急剧增加到59%(45-70%)。 7)2名患者在24小时内需要临时起搏,但在所有情况下7天之内都出现了正常的窦性心律。一名患者因心脏移植术后140天出现房室传导阻滞而永久性起搏器。结论牙山医学中心的心脏移植尚处于发展阶段,但早期结果可与其他国家建立的心脏中心相媲美,尽管必须重新评估其长期随访结果。我们可以得出结论,对于患有晚期心力衰竭的患者,心脏移植是一种有前途的治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号